These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18639637)

  • 1. The immune system and the repair of skeletal muscle.
    Brunelli S; Rovere-Querini P
    Pharmacol Res; 2008 Aug; 58(2):117-21. PubMed ID: 18639637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory interactions between muscle and the immune system during muscle regeneration.
    Tidball JG; Villalta SA
    Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1173-87. PubMed ID: 20219869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies.
    Wallace GQ; McNally EM
    Annu Rev Physiol; 2009; 71():37-57. PubMed ID: 18808326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual and beneficial roles of macrophages during skeletal muscle regeneration.
    Chazaud B; Brigitte M; Yacoub-Youssef H; Arnold L; Gherardi R; Sonnet C; Lafuste P; Chretien F
    Exerc Sport Sci Rev; 2009 Jan; 37(1):18-22. PubMed ID: 19098520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications.
    Pillon NJ; Bilan PJ; Fink LN; Klip A
    Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E453-65. PubMed ID: 23277185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nitric oxide-donor molsidomine modulates the innate inflammatory response in a mouse model of muscular dystrophy.
    Zordan P; Sciorati C; Campana L; Cottone L; Clementi E; Querini PR; Brunelli S
    Eur J Pharmacol; 2013 Sep; 715(1-3):296-303. PubMed ID: 23707352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of muscle injury, repair, and regeneration.
    Tidball JG
    Compr Physiol; 2011 Oct; 1(4):2029-62. PubMed ID: 23733696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ macrophage phenotypic transition is affected by altered cellular composition prior to acute sterile muscle injury.
    Patsalos A; Pap A; Varga T; Trencsenyi G; Contreras GA; Garai I; Papp Z; Dezso B; Pintye E; Nagy L
    J Physiol; 2017 Sep; 595(17):5815-5842. PubMed ID: 28714082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease.
    Serrano AL; Mann CJ; Vidal B; Ardite E; Perdiguero E; Muñoz-Cánoves P
    Curr Top Dev Biol; 2011; 96():167-201. PubMed ID: 21621071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications.
    Ciciliot S; Schiaffino S
    Curr Pharm Des; 2010; 16(8):906-14. PubMed ID: 20041823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?
    Loell I; Lundberg IE
    J Intern Med; 2011 Mar; 269(3):243-57. PubMed ID: 21205023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
    Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
    Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell death, clearance and immunity in the skeletal muscle.
    Sciorati C; Rigamonti E; Manfredi AA; Rovere-Querini P
    Cell Death Differ; 2016 Jun; 23(6):927-37. PubMed ID: 26868912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.
    Venalis P; Lundberg IE
    Rheumatology (Oxford); 2014 Mar; 53(3):397-405. PubMed ID: 23970542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy.
    Morales MG; Cabello-Verrugio C; Santander C; Cabrera D; Goldschmeding R; Brandan E
    J Pathol; 2011 Dec; 225(4):490-501. PubMed ID: 21826667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the immune system to improve ventilatory function in muscular dystrophy.
    Gosselin LE; McCormick KM
    Med Sci Sports Exerc; 2004 Jan; 36(1):44-51. PubMed ID: 14707767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory processes in muscle injury and repair.
    Tidball JG
    Am J Physiol Regul Integr Comp Physiol; 2005 Feb; 288(2):R345-53. PubMed ID: 15637171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and dysregulation of fibrosis in skeletal muscle.
    Serrano AL; Muñoz-Cánoves P
    Exp Cell Res; 2010 Nov; 316(18):3050-8. PubMed ID: 20570674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.